These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 35744840)
1. Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U-2 OS Cells through CD44 and Chemokine Signaling. Fan L; Peng C; Zhu X; Liang Y; Xu T; Xu P; Wu S Molecules; 2022 Jun; 27(12):. PubMed ID: 35744840 [TBL] [Abstract][Full Text] [Related]
2. 15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro. Chen X; Li Q; He Y; Du H; Zhan Z; Zhao H; Shi J; Ye Q; Hu J Anticancer Agents Med Chem; 2017; 17(9):1234-1242. PubMed ID: 26478521 [TBL] [Abstract][Full Text] [Related]
3. Dihydrotanshinone-I modulates Epithelial Mesenchymal Transition (EMT) Thereby Impairing Migration and Clonogenicity of Triple Negative Breast Cancer Cells. Kashyap A; Umar SM; Dev J R A; Prasad CP Asian Pac J Cancer Prev; 2021 Jul; 22(7):2177-2184. PubMed ID: 34319041 [TBL] [Abstract][Full Text] [Related]
4. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Hu T; To KK; Wang L; Zhang L; Lu L; Shen J; Chan RL; Li M; Yeung JH; Cho CH Phytomedicine; 2014 Sep; 21(11):1264-72. PubMed ID: 25172788 [TBL] [Abstract][Full Text] [Related]
5. The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors. Yue J; Hao D; Wang Y; Guo J; Liu S; Meng L; Liu J Biomed Pharmacother; 2024 Jun; 175():116635. PubMed ID: 38653110 [TBL] [Abstract][Full Text] [Related]
6. Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene. Wang X; Xu X; Jiang G; Zhang C; Liu L; Kang J; Wang J; Owusu L; Zhou L; Zhang L; Li W J Cell Mol Med; 2020 Oct; 24(19):11177-11187. PubMed ID: 32860347 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. Ye YT; Zhong W; Sun P; Wang D; Wang C; Hu LM; Qian JQ J Ethnopharmacol; 2017 Mar; 200():107-116. PubMed ID: 28088493 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on HepG2 cells in relation to glutathione perturbation. Lee WY; Chiu LC; Yeung JH Food Chem Toxicol; 2008 Jan; 46(1):328-38. PubMed ID: 17892911 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Determination and Validation of Four Ketones in Li Y; Hou Z; Su F; Chen J; Zhang X; Xu L; Yang D; Liang Z Molecules; 2020 Apr; 25(9):. PubMed ID: 32353926 [No Abstract] [Full Text] [Related]
10. Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats. Wang D; Yu W; Cao L; Xu C; Tan G; Zhao Z; Huang M; Jin J Biopharm Drug Dispos; 2020 Feb; 41(1-2):54-63. PubMed ID: 31943245 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of prostaglandin and nitric oxide production in lipopolysaccharide-treated RAW 264.7 cells by tanshinones from the roots of Salvia miltiorrhiza bunge. Jeon SJ; Son KH; Kim YS; Choi YH; Kim HP Arch Pharm Res; 2008 Jun; 31(6):758-63. PubMed ID: 18563358 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge. Chen X; Yu J; Zhong B; Lu J; Lu JJ; Li S; Lu Y Pharmacol Res; 2019 Jul; 145():104254. PubMed ID: 31054311 [TBL] [Abstract][Full Text] [Related]
13. Dihydrotanshinone I exhibits antitumor effects via β-catenin downregulation in papillary thyroid cancer cell lines. Molteni E; Baldan F; Damante G; Allegri L Sci Rep; 2024 Apr; 14(1):7853. PubMed ID: 38570592 [TBL] [Abstract][Full Text] [Related]
14. Identification of dihydrotanshinone I as an ERp57 inhibitor with anti-breast cancer properties via the UPR pathway. Shi W; Han H; Zou J; Zhang Y; Li H; Zhou H; Cui G Biochem Pharmacol; 2021 Aug; 190():114637. PubMed ID: 34062127 [TBL] [Abstract][Full Text] [Related]
15. Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. Gong Y; Li Y; Lu Y; Li L; Abdolmaleky H; Blackburn GL; Zhou JR Int J Cancer; 2011 Sep; 129(5):1042-52. PubMed ID: 20848589 [TBL] [Abstract][Full Text] [Related]
16. Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies. Hu T; Zhou X; Wang L; Or PM; Yeung JH; Kwan YW; Cho CH Chem Biol Interact; 2015 Mar; 230():1-8. PubMed ID: 25686904 [TBL] [Abstract][Full Text] [Related]
17. Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway. Tan T; Chen J; Hu Y; Wang N; Chen Y; Yu T; Lin D; Yang S; Luo J; Luo X Onco Targets Ther; 2019; 12():5111-5122. PubMed ID: 31308689 [No Abstract] [Full Text] [Related]
18. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro. Zhang Y; Wei RX; Zhu XB; Cai L; Jin W; Hu H Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901 [TBL] [Abstract][Full Text] [Related]
19. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma. Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S. Kong L; Ji H; Gan X; Cao S; Li Z; Jin Y J Orthop Surg Res; 2022 Mar; 17(1):154. PubMed ID: 35264209 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]